BIOPHARMX CORP's ticker is BPMX and the CUSIP is 09072X101. A total of 25 filers reported holding BIOPHARMX CORP in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $740,000 | +179.2% | 6,713,756 | +848.2% | 0.07% | +346.7% |
| Q4 2016 | $265,000 | -27.0% | 708,046 | +8.2% | 0.02% | +7.1% |
| Q3 2016 | $363,000 | -41.6% | 654,462 | -31.6% | 0.01% | -56.2% |
| Q2 2016 | $622,000 | -26.4% | 957,000 | +23.5% | 0.03% | -23.8% |
| Q1 2016 | $845,000 | – | 775,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 16,128,515 | $3,561,000 | 0.46% |
| Virtu Financial LLC | 580,070 | $128,000 | 0.01% |
| FRG Family Wealth Advisors LLC | 30,000 | $7,000 | 0.00% |
| FRANKLIN RESOURCES INC | 9,749,615 | $2,153,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 671,686 | $148,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 16,779 | $4,000 | 0.00% |
| OPPENHEIMER & CO INC | 35,000 | $8,000 | 0.00% |
| CREDIT SUISSE AG/ | 50,003 | $11,000 | 0.00% |
| MORGAN STANLEY | 100 | $0 | 0.00% |
| Invesco Ltd. | 51,964 | $11,000 | 0.00% |